Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
Enphase Energy reinforces its commitment to U.S.-based design and manufacturing of critical power electronics across residential and commercial solar, battery systems, electric vehicle chargers, and next-generation AI data center infrastructure. The company highlights its domestic production facilities in South Carolina and Texas and introduces the…
Aptera Motors Corp. has issued purchase orders for body and chassis components for its first 40 production vehicles, marking a major milestone in transitioning from validation builds to production. Deliveries of these components are expected to begin by October, supporting the company's plan to start production soon. The company is continuing to se…
CBL International Limited has regained compliance with Nasdaq's minimum bid price requirement after executing a 1-for-13 reverse stock split. Nasdaq confirmed the company's stock price has remained above $1.00 for 20 consecutive business days, allowing the company to maintain its listing on the Nasdaq Capital Market under ticker BANL.
CoreCivic announced a new five-year contract with U.S. Immigration and Customs Enforcement to reactivate its Prairie Correctional Facility, which has been idle since 2010. The 1,600-bed facility located in Minnesota will begin intake in Q4 2026, generating estimated annual revenue of approximately $75 million upon full ramp-up by mid-2027.
Mineralys Therapeutics, a biopharmaceutical company targeting hypertension and aldosterone-related diseases, will release its Q2 2026 financial results after market close on August 11, 2026, followed by a conference call and webcast for investors.
Exagen Inc. reported strong financial results for Q2 2026 with record revenue of $19.9 million, a 16% increase year-over-year, driven by growth in autoimmune test volume and higher average selling prices. The company reduced its net loss by nearly 30% compared to the prior year and significantly narrowed its adjusted EBITDA loss to $0.1 million. Ex…
YY Group Holding Limited completed the acquisition of a 95% interest in Xtreme Solutions Pte. Ltd., a profitable Singapore-incorporated distributor, for approximately SGD 4.5 million (USD 3.5 million). The acquisition is expected to be accretive to revenue and net profit starting the following quarter. YY Group plans to leverage its digital marketi…
Telesat Corporation has secured a $2.3 billion contract with Canada's Defence Investment Agency to deliver secure Mil-Ka satellite connectivity to the Canadian Armed Forces across the Arctic. This 15-year agreement expands Telesat Lightspeed constellation by 69 satellites to 225 total, increasing capacity by 44% and positioning Telesat for accelera…
Abeona Therapeutics announced that CMS has granted New Technology Add-On Payment (NTAP) status for its gene therapy ZEVASKYN, intended to treat wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). NTAP status offers supplemental reimbursement above standard hospital payments, recognizing the therapy's clinical benefits and imp…
3D Systems disclosed that CEO Dr. Jeffrey Graves will retire later this year, with a successor to be appointed through an ongoing search process. Dr. Graves will continue as CEO until then and serve as a consultant afterward to ensure a smooth transition. The company highlights the strategic progress made under his leadership, including a focus on …
Creative Realities, Inc., a NASDAQ-listed provider of digital signage and media solutions, will report its financial results for Q2 2026 on August 13, 2026, before market open, followed by a conference call hosted by senior management. The company designs and deploys digital signage experiences and offers SaaS across various sectors including retai…
Harmony Biosciences announced a 30% year-over-year increase in Q2 2026 net revenue for WAKIX, reaching $261.3 million, driven by strong demand and commercial execution. Patient numbers grew by 450 to 8,950. The company reaffirmed its 2026 WAKIX net revenue guidance between $1.0 billion and $1.04 billion. Phase 1 data for BP-205, a potential best-in…
Zevra Therapeutics, a commercial-stage biotech company specializing in rare disease therapeutics, announced its executive leadership will present at the Canaccord Genuity 46th Annual Growth Conference to discuss corporate strategy and upcoming milestones. The company emphasizes its ongoing commercialization of therapies for Niemann-Pick disease typ…
Palvella Therapeutics reported second quarter 2026 financial results and a corporate update highlighting the submission of the first module of its rolling NDA for QTORIN™ rapamycin targeting microcystic lymphatic malformations, planned commercial launch in H1 2027, and upcoming clinical trial initiations for other QTORIN™ drug candidates. The compa…
Dyadic International announced a new strategic development and commercial license agreement with a European biotech firm to expand its portfolio of precision-fermented non-animal dairy proteins. This move enhances Dyadic's food and nutrition pipeline, building on existing collaborations and utilizing its proprietary Dapibus™ fermentation platform f…
Microchip Technology, in collaboration with Micron Technology, showcased an advanced PCIe Gen 6 storage architecture integrating Microchip's Switchtec Gen 6 PCIe switches with Micron's 9650 NVMe SSDs. This demonstration highlights enhanced data throughput, reduced latency, and scalable connectivity designed to meet the demanding requirements of AI,…
Xometry, Inc. (NASDAQ: XMTR) announced record second quarter 2026 results highlighted by 41% year-over-year revenue growth to $229 million, with marketplace revenue increasing 45%. Gross profit rose 34% to $87.2 million, and Adjusted EBITDA improved significantly to $14.1 million, driven by the company's AI-native marketplace expansion, network gro…
Superior Group of Companies, Inc. announced its second quarter 2026 financial results, reporting net sales of $147.8 million, a slight increase from the prior year. Despite a non-cash tradename impairment charge impacting net income to $1.2 million, adjusted net income rose to $3.2 million with adjusted EPS doubling year-over-year. The company conf…
IREN Limited has completed the acquisition of Mirantis, a cloud software and services provider, enhancing IREN's AI workload orchestration, monitoring, and customer support capabilities. This acquisition strengthens IREN’s vertically integrated AI Cloud platform by combining their owned data centers and compute infrastructure with Mirantis' robust …
Invivyd, Inc. announced the grant of stock options totaling 277,500 shares to ten newly hired non-executive employees as inducements under Nasdaq Listing Rule 5635(c)(4). These options have an exercise price of $0.535, matching the stock's closing price on July 31, 2026, with a four-year vesting period and a 10-year term. This move aims to attract …
Rhythm Pharmaceuticals announced its Q2 2026 financial results, highlighting a robust U.S. launch of IMCIVREE for acquired hypothalamic obesity, with over 400 patient starts since FDA approval. Net product revenue reached $71.3 million globally, a 19% sequential increase, driven by strong U.S. sales and growing patient reimbursement. The company al…
Larimar Therapeutics reported encouraging long-term safety and efficacy data for nomlabofusp in an open-label study for Friedreich's ataxia, submitted the first module of a rolling Biologics License Application with the FDA seeking accelerated approval, and plans to start a global Phase 3 confirmatory study in Q3 2026. The company has a strong cash…
Descartes Systems Group will announce its second quarter fiscal 2027 financial results after market close on September 10, 2026. The company's executive management will host a conference call and webcast to discuss the results, providing investors and stakeholders with insight into its performance in the logistics technology sector.
RYTHM, Inc. reported robust financial results for Q2 2026, with revenue from continuing operations reaching $23 million, up 73% quarter-over-quarter. The company achieved net income of $1.2 million and an adjusted EBITDA of $6.4 million, marking a significant turnaround from breakeven in the prior quarter. Growth in THC beverage shipments and new s…
Aclarion, Inc. announced that its Nociscan platform for identifying the source of chronic low back pain is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, the first site in Indiana to offer this technology. This expansion marks growth in Aclarion's provider network and aligns the company with a nationally recognized neuros…
